Obesity Clinical Trial
Official title:
The Effect of Breakfast With Different Macronutrient Composition on PYY, Ghrelin, GLP-1, Glucose Level, VAS for Hunger, VAS for Satiety and Ad Libitum Intake 4 Hours After Breakfast in Obese Women
NCT number | NCT03697486 |
Other study ID # | GuthormonesS3 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | October 2010 |
Est. completion date | July 2011 |
Verified date | October 2018 |
Source | Indonesia University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Gut hormones, such as PYY and ghrelin, are associated with appetite control and obesity.
Protein is thought to be the most satieting nutrient and could affect production of several
gut hormones. This study's objective is to find the effect of breakfast with different
protein composition on PYY, ghrelin, and ad libitum intake four hours after breakfast.
The research methodology was used a clinical trial with 22 obese women participants. Subjects
were given three types of breakfast: low protein consumption (12.4% protein), medium protein
(23.5% protein), and high protein (40,6% protein). PYY and ghrelin level were measured at 0,
15, 60, 120, and 180 minutes after breakfast. Ad libitum meal was given four hours after
breakfast and measured after.
Status | Completed |
Enrollment | 22 |
Est. completion date | July 2011 |
Est. primary completion date | July 2011 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 20 Years to 40 Years |
Eligibility |
Inclusion Criteria: - BMI 25-30 (obese) - with stable body weight within the last 6 months (body weight change less than 4 kg) - normal blood glucose level. Exclusion Criteria: - patients who never had breakfast - patients in weight loss program - patients consuming lipid-absorption inhibitor or appetite-suppressing drugs - patients that have had gastrointestinal tract resection. |
Country | Name | City | State |
---|---|---|---|
Indonesia | Departement of Nutrition, Faculty of Medicine Universitas Indonesia | Jakarta | Jakarta Pusat |
Lead Sponsor | Collaborator |
---|---|
Indonesia University | Dr Cipto Mangunkusumo General Hospital, SEAMEO Regional Centre for Food and Nutrition |
Indonesia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Ghrelin levels at 0 minute | analyzed by ELISA, directly taken after having the breakfast with different protein composition | baseline | |
Primary | Ghrelin levels at 15 minute | analyzed by ELISA, taken 15 minutes after having the breakfast with different protein composition | 15 minutes | |
Primary | Ghrelin levels at 60 minute | analyzed by ELISA, taken 60 minutes after having the breakfast with different protein composition | 60 minutes | |
Primary | Ghrelin levels at 120 minute | analyzed by ELISA, taken 60 minutes after having the breakfast with different protein composition | 120 minutes | |
Primary | Ghrelin levels at 180 minute | analyzed by ELISA, taken 60 minutes after having the breakfast with different protein composition | 180 minutes | |
Primary | PYY levels at 0 minute | analyzed by Radioimmunoassay, directly taken after having the breakfast with different protein composition | baseline | |
Primary | PYY levels at 15 minute | analyzed by Radioimmunoassay, taken 15 minutes after having the breakfast with different protein composition | 15 minutes | |
Primary | PYY levels at 60 minute | analyzed by Radioimmunoassay, taken 60 minutes after having the breakfast with different protein composition | 60 minutes | |
Primary | PYY levels at 120 minute | analyzed by Radioimmunoassay, taken 120 minutes after having the breakfast with different protein composition | 120 minutes | |
Primary | PYY levels at 180 minute | analyzed by Radioimmunoassay, taken 180 minutes after having the breakfast with different protein composition | 180 minutes | |
Primary | GLP-1 levels at 0 minute | analyzed by ELISA, directly taken after having the breakfast with different protein composition | baseline | |
Primary | GLP-1 levels at 15 minute | analyzed by ELISA, taken 15 minutes after having the breakfast with different protein composition | 15 minutes | |
Primary | GLP-1 levels at 60 minute | analyzed by ELISA, taken 60 minutes after having the breakfast with different protein composition | 60 minutes | |
Primary | GLP-1 levels at 120 minute | analyzed by ELISA, taken 120 minutes after having the breakfast with different protein composition | 120 minutes | |
Primary | GLP-1 levels at 180 minute | analyzed by ELISA, taken 180 minutes after having the breakfast with different protein composition | 180 minutes | |
Primary | Glucose levels at 0 minute | analyzed by standard random glucose level from venous blood, taken directly after having the breakfast with different protein composition | baseline | |
Primary | Glucose levels at 15 minute | analyzed by standard random glucose level from venous blood, taken 15 minutes after having the breakfast with different protein composition | 15 minutes | |
Primary | Glucose levels at 60 minute | analyzed by standard random glucose level from venous blood, taken 60 minutes after having the breakfast with different protein composition | 60 minutes | |
Primary | Glucose levels at 120 minute | analyzed by standard random glucose level from venous blood, taken 120 minutes after having the breakfast with different protein composition | 120 minutes | |
Primary | Glucose levels at 180 minute | analyzed by standard random glucose level from venous blood, taken 180 minutes after having the breakfast with different protein composition | 180 minutes | |
Primary | Ad Libitum intake | Mean Ad Libitum intake (calories) in subjects four hours after breakfast with different protein composition | 4 hours | |
Primary | VAS for hunger at 0 minutes | Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), directly taken after having the breakfast with different protein composition | baseline | |
Primary | VAS for hunger at 15 minutes | Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 15 minutes after having the breakfast with different protein composition | 15 minutes | |
Primary | VAS for hunger at 60 minutes | Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 60 minutes after having the breakfast with different protein composition | 60 minutes | |
Primary | VAS for hunger at 120 minutes | Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 120 minutes after having the breakfast with different protein composition | 120 minutes | |
Primary | VAS for hunger at 180 minutes | Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 180 minutes after having the breakfast with different protein composition | 180 minutes | |
Primary | VAS for satiety at 0 minute | Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken directly after having the breakfast with different protein composition | baseline | |
Primary | VAS for satiety at 15 minute | Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 15 minutes after having the breakfast with different protein composition | 15 minutes | |
Primary | VAS for satiety at 60 minute | Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 60 minutes after having the breakfast with different protein composition | 60 minutes | |
Primary | VAS for satiety at 120 minute | Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 120 minutes after having the breakfast with different protein composition | 120 minutes | |
Primary | VAS for satiety at 180 minute | Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 180 minutes after having the breakfast with different protein composition | 180 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |